Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy

Herz

Volumn 37, Issue 6, 2012, Pages 702-705

  Finsterer, J ^a,b   Stollberger C ^b   Berger, E ^c  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c Medical Department   (Austria)

Author keywords

Cardiac involvement; Cardiomyopathy; Dystrophin gene; Heart failure; Neuromuscular disorder

Indexed keywords

CANDESARTAN; CREATINE KINASE; DYSTROPHIN; FUROSEMIDE; IVABRADINE; RAMIPRIL; SPIRONOLACTONE;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; COUGHING; CREATINE KINASE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTROPHIN GENE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENE; GENETIC SCREENING; HEART FAILURE; HEART RATE; HUMAN; HUMAN TISSUE; HYPOTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LEG CRAMP; LEG EDEMA; LIMB WEAKNESS; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUSCLE BIOPSY; SINUS TACHYCARDIA;

ADULT; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; CARDIOMYOPATHY, DILATED; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; TREATMENT OUTCOME;

EID: 84867850252     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3643-8     Document Type: Article

References (18)

1. Aalbers J (2010) Comparison of ivabradine plus beta-blockers versus beta-blocker therapy only. Cardiovasc J Afr 21:116
2. Walcher T, Bernhardt P, Vasic D, et al. (2010) Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration. Mediators Inflamm 2010:751313
3. Birnkrant DJ, Ashwath ML, Noritz GH, et al. (2010) Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report. J Child Neurol 25:1110-1115
4. Kaspar RW, Allen HD, Ray WC, et al. (2009) Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet 2:544-551
5. Ohshita N, Tomiyama Y, Tsutsumi YM, et al. (2011) Anesthetic management of a patient with Becker muscular dystrophy. Masui 60:950-952
6. Romfh A, McNally EM (2010) Cardiac assessment in Duchenne and Becker muscular dystrophies. Curr Heart Fail Rep 7:212-218
7. Yilmaz A, Gdynia HJ, Baccouche H, et al. (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10:50
8. Finsterer J, Stöllberger C (2008) Cardiac involvement in Becker muscular dystrophy. Can J Cardiol 24:786-792
9. Gulati S, Saxena A, Kumar V, Kalra V (2005) Duchenne muscular dystrophy: prevalence and patterns of cardiac involvement. Indian J Pediatr 72:389-393
10. Rayan M, Tawfik M, Alabd A, Gamal A (2011) Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy? Anadolu Kardiyol Derg 11:402-406
11. Swedberg K, Komajda M, Böhm M, et al. (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875-885
12. Tardif JC, O'Meara E, Komajda M, et al. (2011) Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J 32:2507-2515
13. Fox K, Ford I, Steg PG, et al. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807-816
14. Khamaeva AA, Belialov FI, Kerzina LV, et al. (2012) Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease. Kardiologiia 52:15-19
15. Franke J, Schmahl D, Lehrke S, et al. (2011) Adjuvant use of ivabradine in acute heart failure due to myocarditis. Case Report Med 2011:203690
16. Dedkov EI, Zheng W, Christensen LP, et al. (2007) Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen. Am J Physiol Heart Circ Physiol 293:H590-H598
17. Aliyev F, Celiker C, Türkolu C, Uzunhasan I (2010) Successful use of ivabradine in a case of exaggerated autonomic dysfunction. Turk Kardiyol Dern Ars 38:285-289
18. Couvreur N, Tissier R, Pons S, et al. (2010) Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression. Eur Heart J 31:1529-1537